首页> 外文OA文献 >Safety and tolerability of lifitegrast ophthalmic solution 5.0: Pooled analysis of five randomized controlled trials in dry eye disease

【2h】

Safety and tolerability of lifitegrast ophthalmic solution 5.0: Pooled analysis of five randomized controlled trials in dry eye disease

机译：寿命拉伸眼科溶液的安全性和耐受性5.0％：干眼症五种随机对照试验的合并分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kelly K Nichols; Eric D Donnenfeld; Paul M Karpecki; John A Hovanesian; Aparna Raychaudhuri; Amir Shojaei; Steven Zhang;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease [J] . Nichols Kelly K., Donnenfeld Eric D., Karpecki Paul M., European journal of ophthalmology . 2019,第4期

机译：寿命推翻的安全性和耐受性，眼科溶液5.0％：干眼症五种随机对照试验的合并分析
2. Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study [J] . Donnenfeld Eric D., Karpecki Paul M., Majmudar Parag A., Cornea . 2016,第6期

机译：Lifitegrast眼用溶液5.0％对干眼症患者的安全性：为期1年的多中心随机安慰剂对照研究
3. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: combined evidence from 5 randomized controlled trials. [J] . Shojaei Amir, Darvish-Zargar Mahshad, Holland Edward J., Investigative ophthalmology & visual science . 2017,第8期

机译：LifiteGrast眼科溶液5.0％用于治疗干眼症：来自5项随机对照试验的组合证据。
4. HL036337 Ophthalmic Solution: Topical TNF Blocker for Dry Eye Disease [C] . Minjae Shin PEGS . 2015

机译：HL036337眼科溶液：用于干眼症的局部TNF阻滞剂
5. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts - A Cross-Sectional Survey and Bibliometric Analysis [D] . Kumar, Satish. 2015

机译：期刊摘要中牙周疾病随机对照试验的报道质量-横断面调查和文献计量分析
6. Safety and tolerability of lifitegrast ophthalmic solution 5.0:Pooled analysis of five randomized controlled trials in dry eyedisease [O] . Kelly K Nichols, Eric D Donnenfeld, Paul M Karpecki, -1

机译：Lifitegrast眼药水的安全性和耐受性5.0％：五项干眼症随机对照试验的汇总分析疾病
7. Lifitegrast Ophthalmic Solution 5.0 versus Placebo for Treatment of Dry Eye Disease Results of the Randomized Phase III OPUS-2 Study [O] . Tauber Joseph, Karpecki Paul, Latkany Robert, 2015

机译：Lifitegrast眼用溶液相对于安慰剂5.0％用于治疗干眼症随机III期OPUS-2研究的结果

Safety and tolerability of lifitegrast ophthalmic solution 5.0: Pooled analysis of five randomized controlled trials in dry eye disease

著录项

引文网络

相似文献

相关主题

期刊订阅